| Zoetis (ZTS) |
United States |
$60.196B |
37.07 |
| Astellas Pharma (ALPMY) |
Japan |
$26.780B |
13.13 |
| Takeda Pharmaceutical (TAK) |
Japan |
$26.201B |
8.18 |
| Grifols, S.A (GRFS) |
Spain |
$15.161B |
19.34 |
| UCB SA (UCBJF) |
Belgium |
$15.008B |
0.00 |
| Eisai (ESALY) |
Japan |
$14.716B |
25.30 |
| Merck (MKGAF) |
Germany |
$13.654B |
18.63 |
| Ionis Pharmaceuticals (IONS) |
United States |
$9.973B |
21.51 |
| Ono Pharmaceutical (OPHLF) |
Japan |
$9.383B |
20.06 |
| Neurocrine Biosciences (NBIX) |
United States |
$8.886B |
0.00 |
| IPSEN SA ADR (IPSEY) |
France |
$8.634B |
0.00 |
| Sage Therapeutics (SAGE) |
United States |
$8.507B |
0.00 |
| Catalent (CTLT) |
United States |
$8.127B |
32.61 |
| Jazz Pharmaceuticals (JAZZ) |
Ireland |
$7.726B |
10.17 |
| Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) |
Italy |
$7.257B |
19.83 |
| Hikma Pharmaceuticals Plc (HKMPF) |
United Kingdom |
$5.781B |
0.00 |
| STADA ARZNEIMI (STDAF) |
Germany |
$5.547B |
0.00 |
| Orion OYJ (ORINY) |
Finland |
$5.275B |
27.16 |
| Hypermarcas (HYPMY) |
Brazil |
$4.954B |
17.81 |
| FibroGen (FGEN) |
United States |
$3.877B |
96.98 |
| United Therapeutics (UTHR) |
United States |
$3.565B |
0.00 |
| Arrowhead Pharmaceuticals (ARWR) |
United States |
$3.197B |
73.30 |
| Taro Pharmaceutical Industries (TARO) |
Israel |
$3.140B |
11.25 |
| Evotec AG (EVTCY) |
Germany |
$3.032B |
41.51 |
| Nektar Therapeutics (NKTR) |
United States |
$2.999B |
0.00 |
| Tilray (TLRY) |
Canada |
$2.849B |
0.00 |
| PTC Therapeutics (PTCT) |
United States |
$2.695B |
0.00 |
| Xencor (XNCR) |
United States |
$2.309B |
50.35 |
| Zogenix (ZGNX) |
United States |
$2.148B |
0.00 |
| Portola Pharmaceuticals (PTLA) |
United States |
$1.974B |
0.00 |
| Pacira Pharmaceuticals (PCRX) |
United States |
$1.580B |
57.50 |
| CLINIGEN GP (CLIGF) |
United Kingdom |
$1.577B |
0.00 |
| USANA Health Sciences (USNA) |
United States |
$1.491B |
14.95 |
| Corcept Therapeutics (CORT) |
United States |
$1.468B |
20.17 |
| Heron Therapeutics (HRTX) |
United States |
$1.437B |
0.00 |
| Enanta Pharmaceuticals (ENTA) |
United States |
$1.424B |
23.49 |
| Ironwood Pharmaceuticals (IRWD) |
United States |
$1.380B |
0.00 |
| Theravance Biopharma (TBPH) |
Cayman Islands |
$1.218B |
0.00 |
| ArQule (ARQL) |
United States |
$1.110B |
0.00 |
| Radius Health (RDUS) |
United States |
$1.059B |
0.00 |
| Aerie Pharmaceuticals (AERI) |
United States |
$1.034B |
0.00 |
| Spectrum Pharmaceuticals (SPPI) |
United States |
$0.919B |
0.00 |
| AMNEAL PHARMACEUTICALS, INC (AMRX) |
United States |
$0.828B |
3.69 |
| Endo (ENDP) |
Ireland |
$0.684B |
1.20 |
| TherapeuticsMD (TXMD) |
United States |
$0.661B |
0.00 |
| Catalyst Pharmaceuticals (CPRX) |
United States |
$0.636B |
0.00 |
| Indivior (INVVY) |
United States |
$0.575B |
2.08 |
| Karyopharm Therapeutics (KPTI) |
United States |
$0.572B |
0.00 |
| Aurinia Pharmaceuticals Inc (AUPH) |
Canada |
$0.540B |
0.00 |
| Akebia Therapeutics (AKBA) |
United States |
$0.534B |
0.00 |
| Dermira (DERM) |
United States |
$0.482B |
0.00 |
| Concordia (CXRXF) |
Canada |
$0.479B |
0.00 |
| Aptorum Group (APM) |
China |
$0.464B |
0.00 |
| Crinetics Pharmaceuticals (CRNX) |
United States |
$0.457B |
0.00 |
| Translate Bio (TBIO) |
United States |
$0.443B |
0.00 |
| Dova Pharmaceuticals (DOVA) |
United States |
$0.429B |
0.00 |
| BioSpecifics Technologies Corp (BSTC) |
United States |
$0.427B |
19.43 |
| ChemoCentryx (CCXI) |
United States |
$0.410B |
0.00 |
| ImmunoGen (IMGN) |
United States |
$0.409B |
0.00 |
| Flexion Therapeutics (FLXN) |
United States |
$0.407B |
0.00 |
| Siga Technologies (SIGA) |
United States |
$0.405B |
0.95 |
| Organogenesis Holdings (ORGO) |
United States |
$0.400B |
0.00 |
| Collegium Pharmaceutical (COLL) |
United States |
$0.397B |
0.00 |
| Innate Pharma SA (IPHYF) |
France |
$0.374B |
0.00 |
| Corbus Pharmaceuticals Holdings (CRBP) |
United States |
$0.365B |
0.00 |
| CV Sciences (CVSI) |
United States |
$0.340B |
0.00 |
| Rigel Pharmaceuticals (RIGL) |
United States |
$0.323B |
0.00 |
| Xeris Pharmaceuticals (XERS) |
United States |
$0.314B |
0.00 |
| BioCryst Pharmaceuticals (BCRX) |
United States |
$0.296B |
0.00 |
| KalVista Pharmaceuticals (KALV) |
United States |
$0.290B |
0.00 |
| Rafael Holdings (RFL) |
United States |
$0.282B |
0.00 |
| Harpoon Therapeutics (HARP) |
United States |
$0.280B |
0.00 |
| CannTrust Holdings (CTST) |
Canada |
$0.277B |
0.00 |
| Lannett Co Inc (LCI) |
United States |
$0.277B |
2.69 |
| La Jolla Pharmaceutical (LJPC) |
United States |
$0.270B |
0.00 |
| DURECT (DRRX) |
United States |
$0.263B |
0.00 |
| OptiNose (OPTN) |
United States |
$0.263B |
0.00 |
| Recro Pharma (REPH) |
United States |
$0.259B |
0.00 |
| MARKER THERAPEUTICS, INC (MRKR) |
United States |
$0.251B |
0.00 |
| Concert Pharmaceuticals (CNCE) |
United States |
$0.246B |
0.00 |
| Ocular Therapeutix (OCUL) |
United States |
$0.218B |
0.00 |
| Calithera Biosciences (CALA) |
United States |
$0.213B |
0.00 |
| Ardelyx (ARDX) |
United States |
$0.197B |
0.00 |
| Molecular Templates (MTEM) |
United States |
$0.185B |
0.00 |
| AcelRx Pharmaceuticals (ACRX) |
United States |
$0.183B |
0.00 |
| Foamix Pharmaceuticals (FOMX) |
Israel |
$0.177B |
0.00 |
| Nature's Sunshine Products (NATR) |
United States |
$0.175B |
29.26 |
| Taiwan Liposome (TLC) |
Taiwan |
$0.171B |
0.00 |
| Redhill Biopharma (RDHL) |
Israel |
$0.155B |
0.00 |
| GlycoMimetics (GLYC) |
United States |
$0.146B |
0.00 |
| IMV INC (IMV) |
Canada |
$0.145B |
0.00 |
| Generex Biotechnology (GNBT) |
United States |
$0.137B |
0.00 |
| Majesco Entertainment (PTE) |
United States |
$0.133B |
0.00 |
| Jounce Therapeutics (JNCE) |
United States |
$0.123B |
0.00 |
| Galmed Pharmaceuticals (GLMD) |
Israel |
$0.121B |
0.00 |
| MEI Pharma (MEIP) |
United States |
$0.120B |
0.00 |
| Oasmia Pharmaceutical AB (OASM) |
Sweden |
$0.114B |
0.00 |
| Entasis Therapeutics Holdings (ETTX) |
United States |
$0.111B |
0.00 |
| Matinas Biopharma Holdings (MTNB) |
United States |
$0.108B |
0.00 |
| ALLERGY THERAPT (AGYTF) |
United Kingdom |
$0.108B |
0.00 |
| AgeX Therapeutics (AGE) |
United States |
$0.101B |
0.00 |
| Cardiome Pharma (CORV) |
Canada |
$0.097B |
0.00 |
| Mast Therapeutics (SVRA) |
United States |
$0.096B |
0.00 |
| Aquestive Therapeutics (AQST) |
United States |
$0.095B |
0.00 |
| Neos Therapeutics (NEOS) |
United States |
$0.094B |
0.00 |
| Iterum Therapeutics (ITRM) |
Ireland |
$0.094B |
0.00 |
| Nivalis Therapeutics (ALPN) |
United States |
$0.089B |
0.00 |
| ASSERTIO THERAPEUTICS, INC (ASRT) |
United States |
$0.086B |
0.00 |
| Cumberland Pharmaceuticals (CPIX) |
United States |
$0.083B |
31.94 |
| Genocea Biosciences (GNCA) |
United States |
$0.083B |
0.00 |
| MediWound (MDWD) |
Israel |
$0.080B |
0.00 |
| RENEURON GP (RNUGF) |
United Kingdom |
$0.080B |
0.00 |
| Avadel Pharmaceuticals (AVDL) |
Ireland |
$0.078B |
0.00 |
| Natural Alternatives (NAII) |
United States |
$0.075B |
7.52 |
| Otonomy (OTIC) |
United States |
$0.072B |
0.00 |
| Champions Oncology (CSBR) |
United States |
$0.068B |
589.00 |
| Infinity Pharmaceuticals (INFI) |
United States |
$0.068B |
0.00 |
| Adamis Pharmaceuticals (ADMP) |
United States |
$0.066B |
0.00 |
| Novan (NOVN) |
United States |
$0.063B |
0.00 |
| SCYNEXIS (SCYX) |
United States |
$0.062B |
0.00 |
| Opiant Pharmaceuticals (OPNT) |
United States |
$0.060B |
0.00 |
| Pharmaxis (PXSLY) |
Australia |
$0.060B |
0.00 |
| Capnia (SLNO) |
United States |
$0.060B |
0.00 |
| Lipocine (LPCN) |
United States |
$0.060B |
0.00 |
| Medicure (MCUJF) |
Canada |
$0.053B |
0.00 |
| Dipexium Pharmaceuticals (PLXP) |
United States |
$0.053B |
0.00 |
| ElectroCore (ECOR) |
United States |
$0.050B |
0.00 |
| Forward Pharma (FWP) |
Denmark |
$0.044B |
0.00 |
| Bellicum Pharmaceuticals (BLCM) |
United States |
$0.044B |
0.00 |
| India Globalization Capital (IGC) |
United States |
$0.040B |
0.00 |
| CTI BioPharma (CTIC) |
United States |
$0.040B |
0.00 |
| Aclaris Therapeutics (ACRS) |
United States |
$0.040B |
0.00 |
| Mannatechorporated (MTEX) |
United States |
$0.036B |
0.00 |
| Bio-Path Holdings (BPTH) |
United States |
$0.036B |
0.00 |
| Melinta Therapeutics (MLNT) |
United States |
$0.034B |
0.00 |
| PharmAthene (ALT) |
United States |
$0.033B |
0.00 |
| Biomerica (BMRA) |
United States |
$0.028B |
0.00 |
| ProPhase Labs (PRPH) |
United States |
$0.023B |
0.00 |
| Opexa Therapeutics (ACER) |
United States |
$0.023B |
0.00 |
| IsoRay (ISR) |
United States |
$0.023B |
0.00 |
| Heat Biologics (HTBX) |
United States |
$0.019B |
0.00 |
| Summit Therapeutics (SMMT) |
United Kingdom |
$0.018B |
1.44 |
| HANCOCK JAFFE (HJLI) |
United States |
$0.018B |
0.00 |
| Tetraphase Pharmaceuticals (TTPH) |
United States |
$0.015B |
0.00 |
| Achieve Life Sciences (ACHV) |
United States |
$0.015B |
0.00 |
| Cyanotech (CYAN) |
United States |
$0.015B |
0.00 |
| NovaBay Pharmaceuticals (NBY) |
United States |
$0.014B |
0.00 |
| Onconova Therapeutics (ONTX) |
United States |
$0.014B |
0.00 |
| Shineco (TYHT) |
China |
$0.013B |
0.00 |
| Kitov Pharmaceuticals Holdings (KTOV) |
Israel |
$0.012B |
0.00 |
| Regulus Therapeutics (RGLS) |
United States |
$0.012B |
0.00 |
| VAXART, INC (VXRT) |
United States |
$0.010B |
0.00 |
| Sonoma Pharmaceuticals (SNOA) |
United States |
$0.009B |
0.00 |
| RXi Pharmaceuticals (PHIO) |
United States |
$0.009B |
0.00 |
| Eyegate Pharmaceuticals (EYEG) |
United States |
$0.007B |
0.00 |
| Jaguar Animal Health (JAGX) |
United States |
$0.006B |
0.00 |
| Flex Pharma (SLRX) |
United States |
$0.005B |
0.00 |
| Midatech Pharma (MTP) |
United Kingdom |
$0.004B |
0.00 |
| Can-Fite Biopharma (CANF) |
Israel |
$0.003B |
0.00 |
| Cytori Therapeutics Inc (PSTV) |
United States |
$0.003B |
0.00 |
| Xenetic Biosciences (XBIO) |
United States |
$0.002B |
0.00 |
| Advanced Accelerator Applications S.A (AAAP) |
France |
$0.000B |
0.00 |
| Patheon (PTHN) |
Netherlands |
$0.000B |
0.00 |
